Skip to content
Medical Health Aged Care

Interview and filming opportunities – call to lift pregnancy vaccination rates

Immunisation Foundation < 1 mins read

Interview and filming opportunities available today at EPIC Budawang with: 

  • ACT Pharmacist of the Year: Bev Mistry-Cable
  • Catherine Hughes AM, Founder, Immunisation Foundation Australia 

Today is the final day of the Immunisation Foundation of Australia's Immunisation Clinic at the Pregnancy, Baby & Children's Expo at EPIC Budawang between 10am - 3pm.

Expectant mums, dads and grandparents can access immunisations at the pop-up clinic, as well as information about vaccinations recommended during pregnancy. 

A new whitepaper shows Australia's uptake of maternal immunisations have declined in recent years, while vaccine-preventable diseases which can be fatal in babies, including whooping cough, the flu and RSV.

Expert contributors are calling for national targets to drive a consistent approach to information, data and access to vaccinations for pregnant mums across Australia.

For media enquiries:

Nicki Sambuco at [email protected] or on +61 (0) 452 446 084
Chloe Danvers at [email protected] or on +61 (0) 466 626 429

 

More from this category

  • Medical Health Aged Care
  • 07/12/2025
  • 01:41
Takeda Pharmaceutical Company Limited

Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera

52-Week Results from the Phase 3 VERIFY Study of Rusfertide Demonstrated Sustained Hematocrit Control and Response, Defined by Absence of Phlebotomy Eligibility, with No New Safety SignalsThese Data Build on Positive 32-Week Primary Analysis from VERIFY, Which Met its Primary Efficacy Endpoint and All Four Key Secondary EndpointsPatients Crossing Over from Placebo to Rusfertide at 32 Weeks Achieved a Similar Response Rate to Those Initially Randomized to Rusfertide, with 77.9% Achieving Absence of Phlebotomy Eligibility Between Weeks 40-52Four-Year Results from the Combined REVIVE and Long-Term Extension THRIVE Study Demonstrated a 13-Fold Reduction in Annual Rate of Phlebotomies from Baseline NEWARK,…

  • Medical Health Aged Care
  • 06/12/2025
  • 02:11
Arthur D. Little

Arthur D. Little and Vega IT Unveil Joint Venture for Digital Innovation

NEW YORK–BUSINESS WIRE– Arthur D. Little (ADL) and Vega IT today announced the formation of Axceler8 Solutions, a 50/50 joint venture created to design,…

  • Contains:
  • Medical Health Aged Care, Women
  • 05/12/2025
  • 10:11
Breast Cancer Trials

Bec’s Christmas wish amid cancer treatment

This Christmas, Bec’s wish is for her daughters to never face a breast cancer diagnosis like she has. “The only thing tougher than telling…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.